Fatty liver disease doubles risk of death from several diseases
Fatty liver disease, medically called metabolic dysfunction-associated steatotic liver disease (MASLD), affects millions globally. Around one in four adults worldwide...
diseases
New drug approach shows promise in treating metabolic liver diseases
A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental...
Innovative method improves understanding of cellular and molecular mechanisms in kidney diseases
Researchers have demonstrated the feasibility of a morphological-based approach to interpreting spatial transcriptomic (ST) data, helping to improve understanding of...
Global Liver Institute Champions Awareness for Rare Liver Diseases
February is Rare Liver Diseases Month! Join us this February as we launch #RareAware 2025, focusing on the unique experiences...
UK: Purespring Therapeutics raises oversubscribed Series B financing to transform treatment of kidney diseases
Purespring Therapeutics, a UK-based gene therapy company focused on transforming the treatment of kidney diseases, has raised £80m (US$105m) in...
Tanapol Dokkaew, kidney disease survivor and avid advocate for rare diseases
Tanapol has dedicated himself to addressing rare diseases since 2019, predating the Covid-19 pandemic. His efforts have identified over 300...
